Protecting Kids from Pneumonia Waldorf MD

The current recommended dose schedule for 7-valent pneumococcal conjugate vaccine (PCV-7) consists of three primary doses before the age of 6 months, followed by a booster vaccination in the second year of life (3 + 1-dose schedule) in Waldorf.

Bland Merryl MD
(301) 645-4220
Pembrooke Square
Waldorf, MD
 
Shah Minaxi MD
(301) 645-1133
Cambridge Profession
Waldorf, MD
 
Davis Craytonia L MD
(301) 645-1133
Cambridge Profession
Waldorf, MD
 
Mbauya Angelina MD
(301) 645-4220
Pembrooke Square
Waldorf, MD
 
Adeteju Ogunrinde
(301) 870-1789
605 Post Office Rd
Waldorf, MD
Specialty
Pediatrics

Data Provided by:
Dr.Dianna E. Abney
(301) 645-1133
3500 Old Washington Rd # 101
Waldorf, MD
Gender
F
Speciality
Pediatrician
General Information
Accepting New Patients: Yes
RateMD Rating
4.4, out of 5 based on 7, reviews.

Data Provided by:
Aziza C Alam
(301) 843-7222
6 Post Office Rd
Waldorf, MD
Specialty
Pediatrics

Data Provided by:
Margaret A Pimentel, DO
(301) 638-0186
601 Post Office Rd Ste 1A
Waldorf, MD
Specialties
Pediatrics
Gender
Female
Education
Medical School: Des Moines Univ, Coll Osteo Med & Surg, Des Moines Ia 50312
Graduation Year: 1994

Data Provided by:
Neena Ijaz Bhatti, MD
(301) 843-2223
12101 Old Line Ctr
Waldorf, MD
Specialties
Pediatrics
Gender
Female
Education
Medical School: Allama Iqbal Med Coll, Univ Of Punjab, Lahore, Pakistan
Graduation Year: 1987

Data Provided by:
Solomon Valerie MD
(301) 645-4220
Pembrooke Square
Waldorf, MD
 
Data Provided by:

Protecting Kids from Pneumonia

Provided By:

Parents and babies alike will be relieved by new findings that show a reduced-dose schedule for the pneumococcal vaccine can protect infants against pneumonia and other infections.

The current recommended dose schedule for 7-valent pneumococcal conjugate vaccine (PCV-7) consists of three primary doses before the age of 6 months, followed by a booster vaccination in the second year of life (3 + 1-dose schedule). But factors such as questions about the cost-effectiveness of the current PCV-7 dose schedule have led researchers to examine reduced-dose vaccine schedules, according to background information in the study.

The researchers, Dr. Elske J.M. van Gils, of the University Medical Center Utrecht in the Netherlands, and colleagues, studied 1,003 healthy infants who were randomly assigned to receive two doses of PCV-7 at 2 months and 4 months of age, or a 2 + 1-dose schedule at 2, 4 and 11 months of age, or no vaccine (control group). The children were checked after 12 months, 18 months and 24 months for pneumococcal microorganisms in the upper part of the throat behind the nose.

Compared to those in the control group, children in both vaccine groups had far lower rates of microorganisms that can cause pneumonia and other infections, according to the report in the July 8 issue of the Journal of the American Medical Association.

"In conclusion, both two-dose and 2 + 1-dose schedules of PCV-7 significantly reduce vaccine serotype pneumococcal carriage in children. This study supports future implementation of reduced-dose PCV-7 schedules," the researchers concluded.

More information

The Nemours Foundation has more about children and pneumonia.

SOURCE: Journal of the American Medical Association, news release, July 7, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com